Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Nattokinase Market Size & Growth Forecast 2026–2035, By Segments (Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 13474| Published Date: May-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Nattokinase Market size was over USD 34.42 Million in 2025 and is likely to grow at a 3.2% CAGR between 2026 and 2035, surpassing USD 47.16 Million by 2035. The industry revenue for 2026 is assessed at USD 35.35 million.

Base Year Value (2025)
USD 34.42 Million
CAGR (2026-2035)
3.2%
Forecast Year Value (2035)
USD 47.16 Million
Historical Data Period
2022-2025
Largest Region
Asia Pacific
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Nattokinase Market Intelligence Snapshot

Regional Market Dynamics

  • Asia Pacific led the market in 2025 due to strong familiarity with fermented soy products, a robust manufacturing base, and steady demand for enzyme-based wellness products.
  • North America is projected to grow at a 3.65% CAGR, supported by rising interest in preventive health, broader supplement adoption, and expanding retail and e-commerce availability.

Segment Momentum

  • Nutraceuticals lead with 47.91% share due to strong consumer demand for daily cardiovascular wellness supplements and wide availability in capsule and tablet formulations for routine use.
  • Pharmaceuticals are growing fastest due to rising interest in clinically positioned cardiovascular treatments and structured medical use cases beyond general wellness supplementation.

Market Expansion Drivers

  • Rising cardiovascular health awareness increasing demand for natural fibrinolytic dietary supplements.
  • Growing consumer preference for natural functional ingredients accelerating supplement market penetration.
  • Expanding use of nattokinase in functional foods and skincare formulations broadening commercial applications.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Leading companies in the nattokinase market include Japan Bio Science Laboratory Co., Ltd. (Japan), Novonesis A/S (Denmark), BIO-CAT, Inc. (U.S.), Creative Enzymes (U.S.), Daiwa Pharmaceutical Co., Ltd. (Japan), Contek Life Science Co., Ltd. (China), Sungen Bioscience Co., Ltd. (Taiwan), Weidan Biotechnology Co., Ltd. (China), Bioven Ingredients (Spain), Eiffel Biotech Co., Ltd. (China).

Regional and Segment Outlook

Asia Pacific
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising cardiovascular health awareness increasing demand for natural fibrinolytic dietary supplements

As consumer attention shifts toward preventive heart health, the nattokinase market is seeing stronger demand from buyers seeking non-pharmaceutical options associated with circulation support and fibrin management. This awareness changes purchasing behavior in practical ways: consumers are more likely to research ingredient-specific benefits, compare formulations positioned around cardiovascular wellness, and choose supplements that align with daily preventive routines rather than episodic use. That pattern supports repeat purchases, encourages premium positioning around purity and efficacy, and gives brands a clearer basis for product differentiation in a category where trust and health relevance heavily influence conversion.

Growing consumer preference for natural functional ingredients accelerating supplement market penetration

The move away from synthetic-sounding additives and toward recognizable bioactive ingredients is increasing market penetration for the nattokinase market, particularly in wellness segments where label transparency shapes buying decisions. Nattokinase fits well with supplement portfolios built around clean-label, naturally derived, and multifunctional positioning, which makes it easier for manufacturers to introduce it in capsules, combination formulas, and condition-specific products. As retailers and digital sellers give more visibility to natural wellness solutions, this preference directly influences assortment strategy, widens consumer access, and supports broader adoption beyond niche cardiovascular supplement users.

Expanding use of nattokinase in functional foods and skincare formulations broadening commercial applications

Commercial interest in applying this enzyme beyond capsules is supporting market development for the nattokinase market by creating new formulation pathways in food, beverage, and topical wellness products. In functional foods, nattokinase allows manufacturers to embed cardiovascular-support positioning into more routine consumption formats, which can reduce reliance on traditional supplement channels and bring the ingredient into everyday health occasions. In skincare, its inclusion reflects growing interest in bioactive ingredients linked to skin vitality and microcirculation-related benefits, encouraging cross-category product innovation and drawing demand from formulators looking for differentiated natural actives.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising cardiovascular health awareness increasing demand for natural fibrinolytic dietary supplements 1.80% Moderate North America, Asia Pacific High Near Term
Growing consumer preference for natural functional ingredients accelerating supplement market penetration 1.60% Low Europe, North America High Near Term
Expanding use of nattokinase in functional foods and skincare formulations broadening commercial applications 1.20% Moderate Asia Pacific, Europe Emerging Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
Asia Pacific
XX% Market Share in 2025
Asia Pacific (Largest Region) vs North America (Fastest-Growing Region)

Asia Pacific held the largest regional share of the nattokinase market in 2025, bolstered by established consumer familiarity with fermented soy-based products, a strong regional manufacturing base, and more routine incorporation of enzyme-based wellness products into everyday health purchasing. These conditions help sustain market activity by supporting ingredient availability, local production efficiency, and steady demand across supplement and functional health channels where nattokinase is already better recognized.

North America is projected to expand at a 3.65% CAGR over the forecast period, with growth in the nattokinase market being fueled by rising consumer interest in preventive health, broader acceptance of dietary supplements for cardiovascular wellness, and stronger product visibility across retail and e-commerce channels. Adoption is accelerating in practice as more consumers seek non-prescription wellness options and brands respond with clearer positioning, wider distribution, and more targeted education around enzyme-based formulations.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Evidence-Based Supplements

Germany places strong emphasis on ingredient quality, product transparency, and scientifically supported health supplements. Companies in Germany increasingly position nattokinase products within premium wellness portfolios targeting cardiovascular health awareness.

France 🇫🇷

Premium Nutraceutical Focus

France emphasizes premium dietary supplements supported by quality standards and consumer confidence in natural wellness products. Nattokinase suppliers in France increasingly differentiate products through ingredient sourcing and clinically informed positioning.

Italy 🇮🇹

Natural Health Formulations

Italy shows growing interest in nattokinase products that complement preventive health and balanced lifestyle approaches. Supplement manufacturers in Italy prioritize natural formulations and product differentiation to meet evolving consumer wellness preferences.

Japan 🇯🇵

Traditional Functional Nutrition

Japan maintains steady demand for nattokinase through its long-standing association with fermented food traditions and functional nutrition. Manufacturers in Japan continue refining high-quality formulations while supporting innovation in health-focused supplement products.

South Korea 🇰🇷

Functional Ingredient Innovation

South Korea expands nattokinase applications through innovation in dietary supplements and functional health products. Companies in South Korea increasingly develop convenient formulations that appeal to consumers seeking preventive cardiovascular wellness solutions.

United States 🇺🇸

Preventive Wellness Demand

The U.S. nattokinase market benefits from growing consumer interest in cardiovascular wellness and functional dietary supplements. Manufacturers in the U.S. focus on product quality, scientific positioning, and diversified supplement formulations for health-conscious consumers.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Nattokinase Market Share (%), Application, 2025

Nutraceuticals
Pharmaceuticals
Food Additives
others

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Application Segment Analysis: Nutraceuticals (Largest Segment) vs Pharmaceuticals (Fastest-Growing Segment)

Nutraceuticals held a 47.91% share of the nattokinase market in 2025, reflecting the segment’s established role in everyday cardiovascular wellness and preventive health routines. its position is underpinned by steady consumer demand for functional supplements that are easy to incorporate into daily use, especially where nattokinase is positioned as a natural enzyme for circulatory support. The nutraceuticals segment also benefits from broad product availability across capsules, tablets, and blended formulations, which helps maintain volume demand and reinforces its leading share in the nattokinase market.

Pharmaceuticals are emerging as the fastest-growing application in the nattokinase market as interest strengthens around more clinically oriented uses of the enzyme. Growth in this segment is backed by rising attention to evidence-based cardiovascular management and the practical need for more targeted formulations with clearer therapeutic positioning than conventional supplement products. Compared with nutraceuticals, pharmaceuticals are gaining momentum because market expansion is increasingly tied to medical-use potential and structured healthcare applications rather than general wellness consumption alone.

Segment Sub-Segment Largest Segment Fastest Growing
Application Nutraceuticals, Food Additives, Pharmaceuticals, Others Nutraceuticals Pharmaceuticals
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the nattokinase market:

1. Japan Bio Science Laboratory Co. Ltd. (Japan)

2. Novonesis A/S (Denmark)

3. BIO-CAT Inc. (U.S.)

4. Creative Enzymes (U.S.)

5. Daiwa Pharmaceutical Co. Ltd. (Japan)

6. Contek Life Science Co. Ltd. (China)

7. Sungen Bioscience Co. Ltd. (Taiwan)

8. Weidan Biotechnology Co. Ltd. (China)

9. Bioven Ingredients (Spain)

10. Eiffel Biotech Co. Ltd. (China)

Rising interest in enzyme-based health supplements is driving formulation diversification in functional nutrition products. The nattokinase market is evolving as research explores broader cardiovascular and wellness applications. Continuous innovation in extraction and stabilization methods is enhancing product effectiveness and consumer adoption.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
JBSL Apr-26 JBSL secured a patent for its NSK-SD nattokinase ingredient, reinforcing its intellectual property position in functional enzyme-based health solutions. Supported by emerging studies on blood sugar regulation and inflammation reduction, the patent strengthens commercialization prospects and enhances differentiation within the competitive nutraceutical and cardiovascular wellness ingredient market.
Daiken Biomedical Feb-24 Daiken Biomedical utilized a Japan-based patent for its triple-action health formula as part of its growth strategy. The company leverages intellectual property protection to reinforce product credibility and consumer trust, supporting expansion efforts in functional health and nutraceutical markets where differentiation and scientific validation are key competitive drivers.
Gnosis by Lesaffre May-21 Gnosis by Lesaffre acquired NattoPharma, expanding its portfolio in vitamin K2 and natto-derived health ingredients. The acquisition strengthens its position in cardiovascular and bone health nutrition segments by integrating complementary functional ingredients and broadening its ability to serve global nutraceutical markets with a more comprehensive product offering.
Compagnie Des Levures Lesaffre May-21 Compagnie Des Levures Lesaffre completed the acquisition of the remaining 23% stake in NattoPharma ASA, consolidating full ownership of the biotechnology company. The transaction strengthens Lesaffre’s control over natto-derived bioactive ingredient development and supports strategic expansion in functional health and nutraceutical ingredient markets.
Japan Bio Science Laboratory CO., Ltd. Sep-24 Japan Bio Science Laboratory unveiled its NSK-SD nattokinase enzyme at SupplySide West, highlighting its patented and clinically studied formulation. The introduction reinforces its positioning in the functional health ingredient market and supports commercialization efforts for enzyme-based nutraceutical applications targeting cardiovascular wellness.
Kirin Holdings Aug-24 Kirin Holdings and Takanofoods launched a new fermented soybean natto product incorporating Lactococcus lactis strain Plasma, aimed at supporting immune function. The product expansion reflects continued innovation in functional fermented foods, reinforcing competitive activity in health-oriented food formulations linked to cardiovascular and metabolic wellness trends.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Nattokinase Market — Custom Segments

Segment Sub-Segment
No segment data available.

Nattokinase Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the market valuation of nattokinase?

In 2026 the market for nattokinase is worth approximately USD 35.35 million.

What is the projected value of the nattokinase industry by 2035?

Nattokinase Market size is predicted to expand from USD 34.42 million in 2025 to USD 47.16 million by 2035 with growth underpinned by a CAGR above 3.2% between 2026 and 2035.

How is rising cardiovascular health awareness influencing consumer demand in the nattokinase market?

Increasing focus on preventive heart health is driving demand for nattokinase as a natural dietary supplement linked to circulation support. Consumers are increasingly choosing preventive routines, supporting repeat purchases and premium positioning based on perceived cardiovascular benefits.

How are natural ingredient preferences and cross-category applications expanding market opportunities for nattokinase?

Growing preference for natural functional ingredients is boosting adoption in supplements due to clean-label positioning. Expansion into functional foods and skincare is further broadening applications, enabling manufacturers to diversify product formats beyond traditional capsule-based offerings.

Why does Nutraceuticals dominate the nattokinase market?

Nutraceuticals lead with 47.91% share due to strong consumer demand for daily cardiovascular wellness supplements and wide availability in capsule and tablet formulations for routine use.

Why is Pharmaceuticals the fastest-growing application in the nattokinase market?

Pharmaceuticals are growing fastest due to rising interest in clinically positioned cardiovascular treatments and structured medical use cases beyond general wellness supplementation.

Why does Asia Pacific dominate the nattokinase market?

Asia Pacific led the market in 2025 due to strong familiarity with fermented soy products, a robust manufacturing base, and steady demand for enzyme-based wellness products.

Why is North America the fastest-growing nattokinase market?

North America is projected to grow at a 3.65% CAGR, supported by rising interest in preventive health, broader supplement adoption, and expanding retail and e-commerce availability.

Which companies dominate the nattokinase landscape?

Leading companies in the nattokinase market include Japan Bio Science Laboratory Co., Ltd. (Japan), Novonesis A/S (Denmark), BIO-CAT, Inc. (U.S.), Creative Enzymes (U.S.), Daiwa Pharmaceutical Co., Ltd. (Japan), Contek Life Science Co., Ltd. (China), Sungen Bioscience Co., Ltd. (Taiwan), Weidan Biotechnology Co., Ltd. (China), Bioven Ingredients (Spain), Eiffel Biotech Co., Ltd. (China).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →